Is a complete BDMD research report available?

No complete published report is available for Baird Medical Investment Holdings Limited (BDMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Baird Medical Investment Holdings Limited (BDMD)

NASDAQ: BDMD · USD

$0.11

-0.01 (-8.3%)· Recorded snapshot

Market cap	3.4M
Revenue (ttm)	24.5M
Net income (ttm)	-15.9M
EPS (ttm)	-$0.53
Shares out	32M
P/E (forward)	0.9x
Volume	4,964,339
Beta	-1.12

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 24.5M
Net income (ttm): -15.9M
EPS (ttm): -$0.53
P/E (forward): 0.9x
Market cap: 3.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001982444
Company name	Baird Medical Investment Holdings Limited
Country	China
Country code	US
CUSIP number	G0705H103
Earnings date	2026-09-03
Earnings time	bmo
Employees	146
Employees change	3
Employees growth	2.1%
Enterprise value	$21.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	KYG0705H1039
Last 10-K release date	2026-04-24
Last earnings date	2026-09-03
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$3.4M
Market cap category	Nano-Cap
Next earnings date	2027-04-29
Options	No
Price	$0.11
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-11-04
Symbol	BDMD
Website	https://bairdmed.com

Metric

Value

Amount currency

USD

CIK code

0001982444

Company name

Baird Medical Investment Holdings Limited

Country

China

Country code

CUSIP number

G0705H103

Earnings date

2026-09-03

Earnings time

bmo

Employees

146

Employees change

Employees growth

2.1%

Enterprise value

$21.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

KYG0705H1039

Last 10-K release date

2026-04-24

Last earnings date

2026-09-03

Last refreshed

2026-11-04

Last stock split type

Never

Market cap

$3.4M

Market cap category

Nano-Cap

Next earnings date

2027-04-29

Options

Price

$0.11

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-11-04

Symbol

BDMD

Website

https://bairdmed.com

Metric	Value
Earnings yield	-491.25%
EV/FCF	5.33x
EV/Sales	0.9x
FCF / EV yield	18.78%
FCF yield	114.91%
Forward EV/Sales	1.26x
Forward P/E	0.94x
Forward P/S	0.21x
Industry forward P/E	20.29x
Industry P/E	41.22x
P/B ratio	0.11x
P/FCF ratio	0.87x
P/OCF ratio	0.87x
P/S ratio	0.15x
Price / tangible book value	0.1x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-491.25%

EV/FCF

5.33x

EV/Sales

0.9x

FCF / EV yield

18.78%

FCF yield

114.91%

Forward EV/Sales

1.26x

Forward P/E

0.94x

Forward P/S

0.21x

Industry forward P/E

20.29x

Industry P/E

41.22x

P/B ratio

0.11x

P/FCF ratio

0.87x

P/OCF ratio

0.87x

P/S ratio

0.15x

Price / tangible book value

0.1x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-58.52%
EBITDA margin	-54.42%
FCF margin	16.94%
Gross margin	85.63%
Operating margin	-58.52%
Pretax margin	-61.25%
Profit margin	-65.12%
Profit per employee	$-109,238
Revenue per employee	$167,760
ROA	-11.88%
ROA (5Y)	14.97%
ROCE	-36.8%
ROE	-46.03%
ROE (5Y)	54.94%
ROIC	-26.99%
ROIC (5Y)	28.2%
SBC / revenue	55.41%
Tax / revenue	4.77%

Metric

Value

EBIT margin

-58.52%

EBITDA margin

-54.42%

FCF margin

16.94%

Gross margin

85.63%

Operating margin

-58.52%

Pretax margin

-61.25%

Profit margin

-65.12%

Profit per employee

$-109,238

Revenue per employee

$167,760

ROA

-11.88%

ROA (5Y)

14.97%

ROCE

-36.8%

ROE

-46.03%

ROE (5Y)

54.94%

ROIC

-26.99%

ROIC (5Y)

28.2%

SBC / revenue

55.41%

Tax / revenue

4.77%

Metric	Value
EPS growth years	0
FCF growth (QoQ)	32.54%
FCF growth 3Y	-11.2%
Gross profit growth	-24.28%
Gross profit growth (Q)	-24.95%
Gross profit growth 3Y	-5.27%
Net income growth years	0
OCF growth (QoQ)	32.7%
OCF growth 3Y	-17%
Operating income growth (Q)	-83.36%
Revenue growth	-23.12%
Revenue growth (Q)	24.57%
Revenue growth (QoQ)	-31.98%
Revenue growth 3Y	-6.22%
Revenue growth years	0

Metric

Value

EPS growth years

FCF growth (QoQ)

32.54%

FCF growth 3Y

-11.2%

Gross profit growth

-24.28%

Gross profit growth (Q)

-24.95%

Gross profit growth 3Y

-5.27%

Net income growth years

OCF growth (QoQ)

32.7%

OCF growth 3Y

-17%

Operating income growth (Q)

-83.36%

Revenue growth

-23.12%

Revenue growth (Q)

24.57%

Revenue growth (QoQ)

-31.98%

Revenue growth 3Y

-6.22%

Revenue growth years

Metric	Value
Capital expenditures	$2,295
Depreciation and amortization	$1M
EBIT	$-14.3M
EBITDA	$-13.3M
EPS	$-0.53
FCF per share	$0.13
Financing cash flow	$-6.3M
Free cash flow	$4.1M
Free cash flow minus SBC	$-9.4M
Gross profit	$21M
Income taxes	$1.2M
Investing cash flow	$2,295
Net borrowing	$-6.3M
Net cash flow	$-1.9M
Net income	$-15.9M
Operating cash flow minus SBC	$-9.4M
Operating income	$-14.3M
Revenue	$24.5M
Stock-based compensation	$13.6M

Metric

Value

Capital expenditures

$2,295

Depreciation and amortization

$1M

EBIT

$-14.3M

EBITDA

$-13.3M

EPS

$-0.53

FCF per share

$0.13

Financing cash flow

$-6.3M

Free cash flow

$4.1M

Free cash flow minus SBC

$-9.4M

Gross profit

$21M

Income taxes

$1.2M

Investing cash flow

$2,295

Net borrowing

$-6.3M

Net cash flow

$-1.9M

Net income

$-15.9M

Operating cash flow minus SBC

$-9.4M

Operating income

$-14.3M

Revenue

$24.5M

Stock-based compensation

$13.6M

Metric	Value
Altman Z-Score	0.79
Book value per share	$1.09
Debt / equity	0.55
Debt / FCF	4.55
Goodwill	$62,158
Interest coverage	-20.07
Long-term assets	$28.8M
Long-term liabilities	$4.3M
Net cash (debt)	$-18.5M
Net cash / market cap	-511.95%
Net debt / equity	0.53
Net debt / FCF	4.46
Piotroski F-Score	3
Property, plant and equipment	$6.2M
Shareholders' equity	$34.6M
Tangible book value	$34.7M
Tangible book value per share	$1.08
Total assets	$73.8M
Total cash	$397,194
Total debt	$18.9M
Total liabilities	$39.2M
WACC	2.2%

Metric

Value

Altman Z-Score

0.79

Book value per share

$1.09

Debt / equity

0.55

Debt / FCF

4.55

Goodwill

$62,158

Interest coverage

-20.07

Long-term assets

$28.8M

Long-term liabilities

$4.3M

Net cash (debt)

$-18.5M

Net cash / market cap

-511.95%

Net debt / equity

0.53

Net debt / FCF

4.46

Piotroski F-Score

Property, plant and equipment

$6.2M

Shareholders' equity

$34.6M

Tangible book value

$34.7M

Tangible book value per share

$1.08

Total assets

$73.8M

Total cash

$397,194

Total debt

$18.9M

Total liabilities

$39.2M

WACC

2.2%

Metric	Value
Asset turnover	0.32
Current assets	$45.1M
Current liabilities	$34.9M
Current ratio	1.29
Inventory turnover	2.86
Net working capital	$24.3M
Quick ratio	0.89
Working capital	$10.2M
Working capital turnover	1.41

Metric

Value

Asset turnover

0.32

Current assets

$45.1M

Current liabilities

$34.9M

Current ratio

1.29

Inventory turnover

2.86

Net working capital

$24.3M

Quick ratio

0.89

Working capital

$10.2M

Working capital turnover

1.41

Metric	Value
Buyback yield / dilution	-35.98%
Dividend yield	0%
Shareholder yield	-35.98%

Metric

Value

Buyback yield / dilution

-35.98%

Dividend yield

Shareholder yield

-35.98%

Metric	Value
150-day SMA	$1.17
1D price change	-8.29%
1M price change	-86.09%
1M total return	-86.09%
1W price change	-58.2%
1W total return	-58.2%
1Y price change	-91.22%
1Y return CAGR	-91.23%
1Y total return	-91.22%
20-day SMA	$0.43
200-day SMA	$1.32
3M price change	-90.23%
3M total return	-90.23%
3Y price change	-99.02%
3Y return CAGR	-78.58%
3Y total return	-99.02%
50-day SMA	$0.75
50-day SMA vs 200-day SMA	50under200
52-week high	$3.70
52-week high date	2026-03-02
52-week low	$0.07
52-week low date	2026-11-02
6M price change	-94.16%
6M total return	-94.16%
After-hours change	-11.11%
After-hours close	$0.12
After-hours price	$0.10
All-time high	$13.52
All-time high date	2024-09-20
All-time low	$0.07
All-time low date	2026-11-02
Average true range (ATR)	$0.09
Average volume	10.6M
Beta (1Y)	1.61
Beta (2Y)	-0.74
Beta (5Y)	-1.12
Change from 52-week high	-97.1%
Change from 52-week low	48%
Change from all-time high	-99.23%
Change from all-time low	44.14%
Change from open	13.19%
Day's gap	-18.97%
Dollar volume	$532,674
High price	$0.11
Low price	$0.09
Monthly RSI	31.48
Open price	$0.09
Position in 52-week range	62.69%
Premarket change	-18.38%
Premarket close	$0.12
Premarket price	$0.10
Premarket volume	1.5M
Previous close	$0.12
Price vs 150-day SMA	-91.07%
Price vs 20-day SMA	-75.89%
Price vs 200-day SMA	-92.08%
Price vs 50-day SMA	-86.06%
Relative volume	0.47
RSI	12.66
Sharpe ratio	-1.26
Sharpe ratio (3Y)	0.16
Sortino ratio	-1.93
Sortino ratio (3Y)	0.76
Volume	5M
Weekly RSI	22.75
YTD price change	-92.32%
YTD total return	-92.32%

Metric

Value

150-day SMA

$1.17

1D price change

-8.29%

1M price change

-86.09%

1M total return

-86.09%

1W price change

-58.2%

1W total return

-58.2%

1Y price change

-91.22%

1Y return CAGR

-91.23%

1Y total return

-91.22%

20-day SMA

$0.43

200-day SMA

$1.32

3M price change

-90.23%

3M total return

-90.23%

3Y price change

-99.02%

3Y return CAGR

-78.58%

3Y total return

-99.02%

50-day SMA

$0.75

50-day SMA vs 200-day SMA

50under200

52-week high

$3.70

52-week high date

2026-03-02

52-week low

$0.07

52-week low date

2026-11-02

6M price change

-94.16%

6M total return

-94.16%

After-hours change

-11.11%

After-hours close

$0.12

After-hours price

$0.10

All-time high

$13.52

All-time high date

2024-09-20

All-time low

$0.07

All-time low date

2026-11-02

Average true range (ATR)

$0.09

Average volume

10.6M

Beta (1Y)

1.61

Beta (2Y)

-0.74

Beta (5Y)

-1.12

Change from 52-week high

-97.1%

Change from 52-week low

48%

Change from all-time high

-99.23%

Change from all-time low

44.14%

Change from open

13.19%

Day's gap

-18.97%

Dollar volume

$532,674

High price

$0.11

Low price

$0.09

Monthly RSI

31.48

Open price

$0.09

Position in 52-week range

62.69%

Premarket change

-18.38%

Premarket close

$0.12

Premarket price

$0.10

Premarket volume

1.5M

Previous close

$0.12

Price vs 150-day SMA

-91.07%

Price vs 20-day SMA

-75.89%

Price vs 200-day SMA

-92.08%

Price vs 50-day SMA

-86.06%

Relative volume

0.47

RSI

12.66

Sharpe ratio

-1.26

Sharpe ratio (3Y)

0.16

Sortino ratio

-1.93

Sortino ratio (3Y)

0.76

Volume

Weekly RSI

22.75

YTD price change

-92.32%

YTD total return

-92.32%

Metric	Value
Float	6.5M
Float percentage	20.32%
Shares change (QoQ)	7.36%
Shares change (YoY)	35.98%
Shares held by insiders	57.1%
Shares held by institutions	1.39%
Shares outstanding	32M
Short % of float	0.35%
Short % of shares	0.07%
Short ratio	0.3 days

Metric

Value

Float

6.5M

Float percentage

20.32%

Shares change (QoQ)

7.36%

Shares change (YoY)

35.98%

Shares held by insiders

57.1%

Shares held by institutions

1.39%

Shares outstanding

32M

Short % of float

0.35%

Short % of shares

0.07%

Short ratio

0.3 days

Baird Medical Investment Holdings Limited (BDMD)

Price

Financial snapshot

Fair-value bridge

Latest news · BDMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BDMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BDMD

Frequently asked questions